US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

VanEck Biotech ETF

237.30

-0.1532-0.06%

Volume:549

Turnover:130.10K

Market Cap:476.14M

PE:- -

High:237.30

Open:237.30

Low:237.30

Close:237.45

52wk High:246.55

52wk Low:171.63

Shares:2.01M

Float Shares:2.01M

Volume Ratio:0.83

T/O Rate:0.03%

Dividend:0.95

Dividend Rate:0.40%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Centene (CNC), Natera (NTRA) and Vertex Pharmaceuticals (VRTX)

Amgen to deploy Veeva Vault CRM globally

Sino Biopharmaceutical Stock Slips 1.0% in Hong Kong

Analysts Are Bullish on Top Healthcare Stocks: Revolution Medicines (RVMD), ArriVent BioPharma, Inc. (AVBP)

Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day

Revolution Medicines Gets US FDA Breakthrough Therapy Designation for Rasonque To Treat Pancreatic Cancer

MT Newswires Live

Amgen Inc. Stock Outperforms Competitors on Strong Trading Day

Revolution Medicines granted Breakthrough Therapy Designation to Rasonque by FDA

Revolution Medicines Announces U.S. FDA Breakthrough Therapy Designation for Rasonque™ (Daraxonrasib) in Combination with Chemotherapy for First Line Metastatic Pancreatic Cancer

THOMSON REUTERS

Amgen’s Phase 3 Dazodalibep Study Nears Data Spotlight for Sjögren’s Investors

Roche, GSK's Lung-Cancer Drug Candidates Show Promise in China

FDA Approves Shorter Monitoring Time for Amgen’s Imdelltra First Two Doses

Amgen - Imdelltra Monitoring Reduced to 6-8 Hours for First Two Infusions

THOMSON REUTERS

Amgen - Imdelltra Monitoring Remains 6-8 Hours for Third Dose, 3-4 Hours for Cycles 3-4

THOMSON REUTERS

FDA Approves Reduced Monitoring Time for First Two Doses of Imdelltra®

THOMSON REUTERS

Amgen - Patients to Receive Follow-up Assessment After First Two Imdelltra Doses

THOMSON REUTERS

Sino Biopharmaceutical Stock Advances 4.3% in Hong Kong, Outperforms Competitors

Vertex Minerals Revises Timeline for Proposed Securities Issue

Analysts Offer Insights on Healthcare Companies: Revolution Medicines (RVMD) and Cooper Co (COO)

Heart Disease, a Historic Strength for Big Pharma, Becomes a Weakness - Heard on the Street

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigeractivity.com/stock/BBH/news?page=10"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BBH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBH\",,,,,undefined,":{"symbol":"BBH","market":"US","secType":"STK","nameCN":"VanEck Biotech ETF","latestPrice":237.2999,"timestamp":1791208236448,"preClose":237.4531,"halted":0,"volume":549,"delay":0,"changeRate":-0.0006451800376579553,"floatShares":2006503,"shares":2006503,"eps":0,"marketStatus":"Trading","change":-0.1532,"latestTime":"10-05 09:52:23 EDT","open":237.2999,"high":237.2999,"low":237.2999,"amount":130095.00378,"amplitude":0,"askPrice":237.56,"askSize":100,"bidPrice":237.07,"bidSize":200,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1791230400000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":237.4531,"sharesOutstanding":1976503,"nav":237.39591,"aum":476335613.78,"dividendRate":0.004003,"bidAskSpread":0.001118,"postHourTrading":{"tag":"盘后","latestPrice":237.58,"preClose":237.4531,"latestTime":"19:30 EDT","volume":23,"amount":5462.9441,"timestamp":1790983804584,"change":0.1269,"changeRate":0.000534,"amplitude":0},"volumeRatio":0.832823,"impliedVol":0.1952,"impliedVolPercentile":0.4542},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBH\",,,,,undefined,":{"symbol":"BBH","floatShares":2006503,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.832823,"shares":2006503,"dividePrice":0.9498,"high":237.2999,"amplitude":0,"preClose":237.4531,"low":237.2999,"week52Low":171.63,"pbRate":"--","week52High":246.55,"institutionHeld":0,"latestPrice":237.2999,"committee":0.333333,"eps":0,"divideRate":0.004003,"volume":549,"delay":0,"ttmEps":0,"open":237.2999,"prevYearClose":189.2649,"prevWeekClose":237.4531,"prevMonthClose":244.575,"prevQuarterClose":244.575,"fiveDayClose":245.3373,"twentyDayClose":241.1222,"sixtyDayClose":205.546},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBH\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"BBH","amount":0.9565,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"VanEck Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2024-12-23","symbol":"BBH","amount":1.2517,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-23","defaultRemindTime":1734964200000,"name":"VanEck Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-24","payableDate":"2024-12-23","currency":"USD","dateTimestamp":1734930000000,"payDate":"2024-12-24"},{"date":"2023-12-18","symbol":"BBH","amount":0.7127,"announcedDate":"2023-12-15","type":"dividend","market":"US","newRecordDate":"2023-12-19","defaultRemindTime":1702909800000,"name":"VanEck Biotech ETF","recordDate":"2023-12-22","payableDate":"2023-12-19","currency":"USD","dateTimestamp":1702875600000,"payDate":"2023-12-22"},{"market":"US","date":"2022-12-19","symbol":"BBH","amount":0.7488,"defaultRemindTime":1671460200000,"name":"VanEck Biotech ETF","recordDate":"2022-12-23","payableDate":"2022-12-20","currency":"USD","type":"dividend","dateTimestamp":1671426000000},{"market":"US","date":"2021-12-20","symbol":"BBH","amount":0.3972,"defaultRemindTime":1640010600000,"name":"VanEck Vectors Biotech ETF","recordDate":"2021-12-27","payableDate":"2021-12-21","currency":"USD","type":"dividend","dateTimestamp":1639976400000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBH\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-19","recordDate":"2016-12-21","paymentDate":"2016-12-23","value":0.327,"currency":"USD"},{"executeDate":"2018-12-20","recordDate":"2018-12-21","paymentDate":"2018-12-27","value":0.006,"currency":"USD"},{"executeDate":"2019-12-23","recordDate":"2019-12-24","paymentDate":"2019-12-30","value":0.4724,"currency":"USD"},{"executeDate":"2020-12-21","recordDate":"2020-12-22","paymentDate":"2020-12-28","value":0.6079,"currency":"USD"},{"executeDate":"2021-12-20","recordDate":"2021-12-21","paymentDate":"2021-12-27","value":0.3972,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BBH\",pageSize:20,pageCount:10,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667641173","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Centene (CNC), Natera (NTRA) and Vertex Pharmaceuticals (VRTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2667641173","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667641173?lang=en_us&edition=fundamental","pubTime":"2026-09-15 19:20","pubTimestamp":1789471221,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Centene (CNC), Natera (NTRA) and Vertex Pharmaceut...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-centene-cnc-natera-ntra-and-vertex-pharmaceuticals-vrtx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-centene-cnc-natera-ntra-and-vertex-pharmaceuticals-vrtx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBBQ","TBXU","LU0823416689.USD","PBE","LU1585245621.USD","IDNA","VRTX","BBH","LU2236285917.USD","BK4567","LU2462157665.USD","NTRA","LU0128526141.USD","LU1035775433.USD","LU0234570918.USD","LU0012050646.USD","LABU","HCSG","LU0053671581.USD","BK4581","BK4154","CNCG","IBB","BK4585","LU2456880835.USD","IE00B19Z3581.USD","LU1430594728.SGD","BIB","BK4023","XBI","LU0648000940.SGD","LU1291159041.SGD","BK4137","LU1988902786.USD","LU0289739699.SGD","XLV","LU1674673691.USD","BK4139","IE0002270589.USD","CNC","LU0859254822.USD","HELX","IE00B19Z9Z06.USD","LU2065169927.USD","GNMX","GNOM","IE0009355771.USD","LU0130518102.USD","LU2065171311.SGD","VERX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667641127","title":"Amgen to deploy Veeva Vault CRM globally","url":"https://stock-news.laohu8.com/highlight/detail?id=2667641127","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667641127?lang=en_us&edition=fundamental","pubTime":"2026-09-15 19:10","pubTimestamp":1789470620,"startTime":"0","endTime":"0","summary":"Veeva Systems (VEEV) announced that Amgen (AMGN) plans to deploy Veeva Vault CRM globally, building on a collaboration spanning more than a decade....","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/amgen-to-deploy-veeva-vault-crm-globally-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/amgen-to-deploy-veeva-vault-crm-globally-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PJP","LGHT","IBB","04332","BK4528","IE0009355771.USD","LU2242646821.SGD","LU0889565916.HKD","LU0170899867.USD","IE00B2B36J28.USD","LU0109394709.USD","LU2468319806.SGD","LU2089984988.USD","AMGN","LU1057294990.SGD","LU1989764664.SGD","LU1571399168.USD","BBH","BK4139","LU1983299246.USD","BK4613","LU0868494617.USD","TBXU","LU1989764748.USD","LU0266013472.USD","BK4581","IE0002141913.USD","LU2242652126.USD","LU2112291526.USD","BK4534","EKG","SG9999001440.SGD","BK4599","VEEV","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","PBE","IE00BJT1NW94.SGD","BK4566","BK4533","BK4504","LU1023059063.AUD","LU0058720904.USD","LU0122379950.USD","IBBQ","LU0006306889.USD","BK4167","BIB","LU0106261372.USD","BK4588","IE00B4R5TH58.HKD","LU0289739699.SGD","LU0320765992.SGD","LU1061106388.HKD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667109456","title":"Sino Biopharmaceutical Stock Slips 1.0% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2667109456","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667109456?lang=en_us&edition=fundamental","pubTime":"2026-09-15 16:33","pubTimestamp":1789461180,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. slipped 1.0% to 5.42 Hong Kong dollars on what proved to be an all-around poor trading session for the Hong Kong stock market, with the Hang Seng Index falling 1.0% to 24667.24.Sino Biopharmaceutical Ltd. closed 38% below its 52-week high of HK$8.81, which the company achieved Sept. 16.The stock demonstrated a mixed performance when compared to some of its competitors, as CSPC Pharmaceutical Group Ltd. fell 1.9% and Amgen Inc. remained unchanged.Trading volume totaled 59.4 million shares, compared to the 50-day average of 95.3 million shares.Data source: Dow Jones Market Data, FactSet","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","PJP","BK1191","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","BK4581","IBBQ","BK4534","IE0002141913.USD","PBE","LU0109394709.USD","BK1589","BIB","BBH","LU2089984988.USD","IBB","LU1061106388.HKD","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","BK4588","LU0320765992.SGD","LU1571399168.USD","LU2468319806.SGD","IE0009355771.USD","SG9999001440.SGD","LU2242646821.SGD","BK4599","BK1521","IE00BZ08YS42.EUR","LU0122379950.USD","LU0868494617.USD","01177","LU0289739699.SGD","LU1057294990.SGD","BK1515","IE00B4R5TH58.HKD","IE00BZ08YT58.USD","IE00BZ08YR35.GBP","BK4533","BK4585","HK0000165453.HKD","LU2112291526.USD","LU2242652126.USD","LU1983299246.USD","AMGN","LU1023059063.AUD","TBXU","LU0889565916.HKD","BK4139","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667966776","title":"Analysts Are Bullish on Top Healthcare Stocks: Revolution Medicines (RVMD), ArriVent BioPharma, Inc. (AVBP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2667966776","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667966776?lang=en_us&edition=fundamental","pubTime":"2026-09-15 05:10","pubTimestamp":1789420212,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Revolution Medicines (RVMD) and ArriVent BioPharma, ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-revolution-medicines-rvmd-arrivent-biopharma-inc-avbp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-revolution-medicines-rvmd-arrivent-biopharma-inc-avbp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IDNA","XBI","IE00BJJMRZ35.SGD","BK4588","BBH","HCSG","CANC","LU0128526141.USD","IE0009355771.USD","IE0009354923.USD","BK4581","LU0109394709.USD","LABU","BK4585","XLV","IE00BJT1NW94.SGD","PTH","BK4139","LU0889565916.HKD","BK4137","IE00BFTCPJ56.SGD","AVBP","LU0029874061.USD","IE00B4R5TH58.HKD","LU0320765992.SGD","IE0002141913.USD","RVMD","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667695453","title":"Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2667695453","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667695453?lang=en_us&edition=fundamental","pubTime":"2026-09-15 04:36","pubTimestamp":1789418160,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  rallied 1.87% to $146.41 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index  falling 0.48% to 7,619.98 and Dow Jones Industrial Average  falling 0.29% to 52,421.20.The stock's rise snapped a five-day losing streak.Gilead Sciences Inc. closed 6.92% below its 52-week high of $157.29, which the company achieved on February 11th.The stock outperformed some of its competitors Monday, as Johnson & Johnson  rose 0.28% to $266.32, Pfizer Inc.  remained unchanged, and Abbott Laboratories  rose 1.12% to $103.09.Trading volume  remained 1.5 million below its 50-day average volume of 6.3 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 14, 2026.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","LU1934455277.USD","BK4578","LU1061106388.HKD","LU0122379950.USD","LU0114720955.EUR","LU1674673691.USD","BIB","SG9999015952.SGD","LU0320765992.SGD","LU0859254822.USD","TMED","BK4583","LU0965509010.AUD","BK4568","LU2468319806.SGD","LU1023059063.AUD","IE00B19Z3581.USD","IE00B7SZLL34.SGD","LU0965508806.USD","BBH","LU0109394709.USD","LU1585245621.USD","LU2089984988.USD","LU0289739699.SGD","LU1057294990.SGD","BK4566","LU1571399168.USD","MEDI","LU0823416689.USD","LU2324357040.USD","LU1430594728.SGD","LU0965509101.SGD","IE00B19Z3B42.SGD","IE00B3T34201.USD","LU0882574055.USD","LU1934455863.HKD","LU2357627491.SGD","LU0861579265.USD","IE00BZ1G4Q59.USD","SG9999015986.USD","LU1839511570.USD","GILD","IE00BKVL7J92.USD","LU1066053197.SGD","BK4585","SG9999015978.USD","LU0234570918.USD","LU1066051498.USD","IBB","BMED","LU2087621335.USD","LU1037948541.HKD","IE00BSNM7G36.USD","SG9999015945.SGD","BK4139","LU0889565916.HKD","TBXU","LU2112291526.USD","LU0965509283.SGD","BK4550","BK4588","LU0058720904.USD","LU1778281490.HKD","LU1934455194.USD","IBBQ","LU1037948897.HKD","IE0002270589.USD","LU1674673428.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667695932","title":"Revolution Medicines Gets US FDA Breakthrough Therapy Designation for Rasonque To Treat Pancreatic Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2667695932","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667695932?lang=en_us&edition=fundamental","pubTime":"2026-09-15 04:35","pubTimestamp":1789418122,"startTime":"0","endTime":"0","summary":"Revolution Medicines  said Monday that the US Food and Drug Administration has given breakthrough therapy designation to Rasonque plus chemotherapy to treat pancreatic cancer.The company said Rasonque was recently approved by the US FDA to treat adults with metastatic pancreatic cancer who have received at least one systemic therapy or who are not candidates for multiagent systemic therapy.Revolution said the use of Rasonque plus chemotherapy for treatment-naive metastatic pancreatic adenocarcinoma is still investigational, with safety and efficacy not yet established.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RVMD","IDNA","IE00B4R5TH58.HKD","IE0009355771.USD","IE00BJT1NW94.SGD","IE0002141913.USD","IE00B2B36J28.USD","LU0889565916.HKD","PTH","CANC","BK4588","LU0320765992.SGD","IE00BJJMRZ35.SGD","BK4139","LU0109394709.USD","LABU","BBH","IE00BFTCPJ56.SGD","IE0009354923.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667695950","title":"Amgen Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2667695950","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667695950?lang=en_us&edition=fundamental","pubTime":"2026-09-15 04:35","pubTimestamp":1789418100,"startTime":"0","endTime":"0","summary":"DJ Amgen Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Amgen Inc.  advanced 1.10% to $381.50 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index  falling 0.48% to 7,619.98 and Dow Jones Industrial Average  falling 0.29% to 52,421.20.The stock's rise snapped a five-day losing streak.Amgen Inc. closed 14.66% below its 52-week high of $447.03, which the company achieved on August 25th.The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Johnson & Johnson  rose 0.28% to $266.32, Pfizer Inc.  remained unchanged, and AbbVie Inc.  rose 1.81% to $261.77.Trading volume  eclipsed its 50-day average volume of 2.5 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 14, 2026.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TBXU","AMGN","BBH","IBBQ","BK4585","LU1061106388.HKD","LU0058720904.USD","LU2112291526.USD","LU2242652126.USD","LU0109394709.USD","LU2468319806.SGD","IE00B4R5TH58.HKD","LU2089984988.USD","IE00BJJMRZ35.SGD","BK4139","IE00B2B36J28.USD","LU0868494617.USD","PBE","BK4588","IE0009355771.USD","BK4581","LU0889565916.HKD","IE00BJT1NW94.SGD","SG9999001440.SGD","BIB","LU0289739699.SGD","IBB","LU1571399168.USD","BK4533","LU1057294990.SGD","BK4599","BK4566","LU0320765992.SGD","LU1023059063.AUD","04332","LU1983299246.USD","LU2242646821.SGD","BK4534","IE00BFTCPJ56.SGD","LU0122379950.USD","PJP","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667953426","title":"Revolution Medicines granted Breakthrough Therapy Designation to Rasonque by FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2667953426","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667953426?lang=en_us&edition=fundamental","pubTime":"2026-09-15 04:15","pubTimestamp":1789416936,"startTime":"0","endTime":"0","summary":"Revolution Medicines (RVMD) announced that the FDA has granted Breakthrough Therapy Designation to Rasonque, the company’s RAS multi-selective inhi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/revolution-medicines-granted-breakthrough-therapy-designation-to-rasonque-by-fda-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/revolution-medicines-granted-breakthrough-therapy-designation-to-rasonque-by-fda-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0889565916.HKD","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","LU0320765992.SGD","RVMD","BBH","IE00BFTCPJ56.SGD","BK4585","PTH","IE0002141913.USD","IE0009354923.USD","BK4588","IE00B4R5TH58.HKD","IDNA","IE0009355771.USD","LU0109394709.USD","BK4139","CANC","LABU","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667769375","title":"Revolution Medicines Announces U.S. FDA Breakthrough Therapy Designation for Rasonque™ (Daraxonrasib) in Combination with Chemotherapy for First Line Metastatic Pancreatic Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2667769375","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667769375?lang=en_us&edition=fundamental","pubTime":"2026-09-15 04:05","pubTimestamp":1789416300,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nTUA3JTDPL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","IDNA","LU0889565916.HKD","IE0009355771.USD","PTH","IE0002141913.USD","BBH","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","CANC","LU0320765992.SGD","RVMD","IE00B2B36J28.USD","LU0109394709.USD","IE0009354923.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667667070","title":"Amgen’s Phase 3 Dazodalibep Study Nears Data Spotlight for Sjögren’s Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2667667070","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667667070?lang=en_us&edition=fundamental","pubTime":"2026-09-15 00:30","pubTimestamp":1789403411,"startTime":"0","endTime":"0","summary":"Amgen Inc ($AMGN) announced an update on their ongoing clinical study. The phase 3 study A Phase 3 Randomized, Double-blind, Placebo-controlled Stu...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/amgens-phase-3-dazodalibep-study-nears-data-spotlight-for-sjogrens-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/amgens-phase-3-dazodalibep-study-nears-data-spotlight-for-sjogrens-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2089984988.USD","SG9999001440.SGD","BK4139","IBBQ","IBB","BK4534","IE00BJT1NW94.SGD","LU0868494617.USD","BIB","LU1061106388.HKD","IE00BFTCPJ56.SGD","BBH","LU0889565916.HKD","LU0320765992.SGD","ISBC","LU2468319806.SGD","BK4581","LU0289739699.SGD","IE00BJJMRZ35.SGD","LU1023059063.AUD","LU2112291526.USD","LU0058720904.USD","BK4585","LU0122379950.USD","BK4533","IE0002141913.USD","PJP","BK4211","IE0009355771.USD","TBXU","BK4588","LU1057294990.SGD","LU0109394709.USD","IE00B2B36J28.USD","LU1571399168.USD","LU2242652126.USD","IE00B4R5TH58.HKD","LU2242646821.SGD","PBE","AMGN","BK4599","BK4566","LU1983299246.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667661729","title":"Roche, GSK's Lung-Cancer Drug Candidates Show Promise in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2667661729","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667661729?lang=en_us&edition=fundamental","pubTime":"2026-09-14 22:04","pubTimestamp":1789394640,"startTime":"0","endTime":"0","summary":"1404 GMT - Roche Holding and GSK's Chinese partners reported strong clinical-trial data for their respective lung-cancer drug candidates in China-only clinical trials, analysts at J.P. Morgan write in a research note. Both drugs, one from GSK and partner Hansoh Pharmaceutical and another from Roche and MediLink, showed a 54% improvement in overall survival rates in the trials. This seems competitive relative to a 40% benefit shown by Amgen's Imdelltra in a global trial, the analysts say. Roche and MediLink's candidate tam-peli has a better tolerability profile than GSK and Hansoh's ris-rez, they add. Ris-rez has better median overall-survival data, but it will be important to confirm this result in a global trial, according to JPM. GSK shares rise 4.6% and Roche's jump 5.7%, while Hansoh's close 5.1% higher.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009355771.USD","03692","BK1589","LU1983299246.USD","BK4599","LU0058720904.USD","BBH","BK1191","GSK","IE0002141913.USD","03165","AMGN","IE00B2B36J28.USD","PJP","HRTS","RHHBY","LU2242652126.USD","LU2468319806.SGD","LU0109394709.USD","IE00B4R5TH58.HKD","BK4533","GSK.UK","GSKH","IBB","BK4566","BK4585","TBXU","LU1057294990.SGD","CANC","BK4532","IE00BJT1NW94.SGD","IBBQ","LU0122379950.USD","LU1061106388.HKD","LU2089984988.USD","LU1829250122.USD","SG9999001440.SGD","LU0889565916.HKD","LU1571399168.USD","LU2112291526.USD","BK4007","IE00BJJMRZ35.SGD","BK4534","PBE","LU0320765992.SGD","LU1023059063.AUD","LU0868494617.USD","BK4581","LU0289739699.SGD","BIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667669562","title":"FDA Approves Shorter Monitoring Time for Amgen’s Imdelltra First Two Doses","url":"https://stock-news.laohu8.com/highlight/detail?id=2667669562","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667669562?lang=en_us&edition=fundamental","pubTime":"2026-09-14 21:06","pubTimestamp":1789391173,"startTime":"0","endTime":"0","summary":"FDA approves shorter monitoring time for Amgen’s Imdelltra first two dosesFDA cleared a label update for Amgen’s IMDELLTRA that cuts post-infusion monitoring for the first two doses to 6-8 hours.Prior","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nNDLtJX3g:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1057294990.SGD","BK4534","IE00BJJMRZ35.SGD","BBH","PBE","LU0320765992.SGD","BK4599","LU0122379950.USD","LU0889565916.HKD","LU0868494617.USD","BK4585","BIB","LU1983299246.USD","BK4581","SG9999001440.SGD","IE0009355771.USD","IE0002141913.USD","LU0058720904.USD","IBB","AMGN","IE00B2B36J28.USD","IBBQ","LU2112291526.USD","LU1023059063.AUD","IE00B4R5TH58.HKD","BK4588","IE00BFTCPJ56.SGD","BK4566","LU0289739699.SGD","IE00BJT1NW94.SGD","PJP","LU2242646821.SGD","LU2242652126.USD","LU1061106388.HKD","LU2089984988.USD","LU2468319806.SGD","BK4533","TBXU","LU0109394709.USD","LU1571399168.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667778666","title":"Amgen - Imdelltra Monitoring Reduced to 6-8 Hours for First Two Infusions","url":"https://stock-news.laohu8.com/highlight/detail?id=2667778666","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667778666?lang=en_us&edition=fundamental","pubTime":"2026-09-14 21:00","pubTimestamp":1789390805,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nTUA41PDLW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2089984988.USD","PBE","IE00BJJMRZ35.SGD","LU1061106388.HKD","BK4534","LU2112291526.USD","BK4588","BBH","IE0009355771.USD","LU2242652126.USD","TBXU","BK4581","BIB","BK4566","LU0109394709.USD","LU2242646821.SGD","BK4585","LU2468319806.SGD","IE00BJT1NW94.SGD","BK4139","IBB","LU0889565916.HKD","LU1983299246.USD","LU1057294990.SGD","PJP","LU0868494617.USD","IE00BFTCPJ56.SGD","IBBQ","LU0289739699.SGD","IE00B4R5TH58.HKD","LU0320765992.SGD","IE0002141913.USD","BK4533","SG9999001440.SGD","LU0058720904.USD","LU1023059063.AUD","LU1571399168.USD","BK4599","AMGN","IE00B2B36J28.USD","LU0122379950.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667774666","title":"Amgen - Imdelltra Monitoring Remains 6-8 Hours for Third Dose, 3-4 Hours for Cycles 3-4","url":"https://stock-news.laohu8.com/highlight/detail?id=2667774666","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667774666?lang=en_us&edition=fundamental","pubTime":"2026-09-14 21:00","pubTimestamp":1789390805,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nTUA41PDLW:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SG9999001440.SGD","BK4533","IE00B4R5TH58.HKD","IBB","LU1061106388.HKD","LU0109394709.USD","LU0868494617.USD","BK4566","LU1571399168.USD","BK4599","LU0320765992.SGD","BK4581","TBXU","LU0889565916.HKD","IE00BJJMRZ35.SGD","LU2112291526.USD","IE0002141913.USD","PBE","BK4534","IE00BJT1NW94.SGD","LU2468319806.SGD","BK4585","IE0009355771.USD","LU1983299246.USD","BK4139","LU1057294990.SGD","AMGN","PJP","LU0122379950.USD","BIB","IE00BFTCPJ56.SGD","LU0058720904.USD","LU1023059063.AUD","BBH","BK4588","IE00B2B36J28.USD","LU2242646821.SGD","LU0289739699.SGD","LU2089984988.USD","IBBQ","LU2242652126.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667701666","title":"FDA Approves Reduced Monitoring Time for First Two Doses of Imdelltra®","url":"https://stock-news.laohu8.com/highlight/detail?id=2667701666","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667701666?lang=en_us&edition=fundamental","pubTime":"2026-09-14 21:00","pubTimestamp":1789390805,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nTUA41PDLW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2468319806.SGD","IBBQ","IE0009355771.USD","LU1023059063.AUD","BK4566","LU2242646821.SGD","PBE","IE00BJT1NW94.SGD","IBB","LU1061106388.HKD","SG9999001440.SGD","IE00BJJMRZ35.SGD","BK4533","LU0109394709.USD","BK4585","BK4139","LU1571399168.USD","BK4534","LU2089984988.USD","LU1057294990.SGD","LU0868494617.USD","LU0320765992.SGD","LU0058720904.USD","BK4581","BK4599","LU0889565916.HKD","IE00B2B36J28.USD","LU1983299246.USD","LU2112291526.USD","LU2242652126.USD","LU0122379950.USD","IE00BFTCPJ56.SGD","PJP","IE00B4R5TH58.HKD","BK4588","LU0289739699.SGD","TBXU","BIB","BBH","AMGN","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667082666","title":"Amgen - Patients to Receive Follow-up Assessment After First Two Imdelltra Doses","url":"https://stock-news.laohu8.com/highlight/detail?id=2667082666","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667082666?lang=en_us&edition=fundamental","pubTime":"2026-09-14 21:00","pubTimestamp":1789390805,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nTUA41PDLW:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0868494617.USD","LU1057294990.SGD","BK4588","BK4581","LU2112291526.USD","BK4139","IE00B2B36J28.USD","BK4599","IE00B4R5TH58.HKD","PJP","LU0109394709.USD","BIB","LU1061106388.HKD","BK4585","LU2089984988.USD","IE00BJT1NW94.SGD","TBXU","BK4566","LU0320765992.SGD","BK4533","IE0009355771.USD","LU1571399168.USD","LU2242652126.USD","LU0889565916.HKD","AMGN","IBB","IE0002141913.USD","LU2468319806.SGD","IE00BFTCPJ56.SGD","LU1983299246.USD","BBH","BK4534","LU0289739699.SGD","LU2242646821.SGD","LU1023059063.AUD","LU0122379950.USD","LU0058720904.USD","PBE","IBBQ","SG9999001440.SGD","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667659991","title":"Sino Biopharmaceutical Stock Advances 4.3% in Hong Kong, Outperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2667659991","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667659991?lang=en_us&edition=fundamental","pubTime":"2026-09-14 16:30","pubTimestamp":1789374600,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. advanced 4.3% to 5.48 Hong Kong dollars on what proved to be an all-around great trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.5% to 24917.60.The stock's rise snapped a three-day losing streak.Sino Biopharmaceutical Ltd. closed 38% below its 52-week high of HK$8.86, which the company achieved Sept. 15.The stock outperformed some of its competitors, as CSPC Pharmaceutical Group Ltd. rose 1.8% and Amgen Inc. remained unchanged.Trading volume totaled 72.9 million shares, compared to the 50-day average of 98.8 million shares.Data source: Dow Jones Market Data, FactSet","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","BK1521","IE00BJT1NW94.SGD","LU1023059063.AUD","LU1061106388.HKD","01177","BK4585","IE00BZ08YR35.GBP","AMGN","LU0058720904.USD","LU1057294990.SGD","IE00BFTCPJ56.SGD","LU1983299246.USD","BK4581","BK1515","BK1589","IE00BZ08YT58.USD","BK4533","LU2242646821.SGD","BBH","HK0000165453.HKD","SG9999001440.SGD","TBXU","BK1191","BK4534","IE00BZ08YS42.EUR","BK4588","LU0889565916.HKD","LU1571399168.USD","LU0868494617.USD","LU0320765992.SGD","BK4566","PBE","PJP","LU2112291526.USD","IE0002141913.USD","BIB","IE00BJJMRZ35.SGD","LU2468319806.SGD","IE00B2B36J28.USD","LU0109394709.USD","LU2242652126.USD","LU0289739699.SGD","LU2089984988.USD","BK4599","IE0009355771.USD","LU0122379950.USD","IE00B4R5TH58.HKD","IBB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667635488","title":"Vertex Minerals Revises Timeline for Proposed Securities Issue","url":"https://stock-news.laohu8.com/highlight/detail?id=2667635488","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667635488?lang=en_us&edition=fundamental","pubTime":"2026-09-14 07:40","pubTimestamp":1789342824,"startTime":"0","endTime":"0","summary":"Vertex Minerals Ltd. ( ($AU:VTX) ) has provided an update. Vertex Minerals Ltd. has updated its proposed securities placement timetable, revising t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-minerals-revises-timeline-for-proposed-securities-issue?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-minerals-revises-timeline-for-proposed-securities-issue?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0320765992.SGD","LU1585245621.USD","BK4585","LU0109394709.USD","LU1674673691.USD","GNMX","IE00B2B36J28.USD","LU0889565916.HKD","LU1559883803.SGD","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","LU1815336091.USD","LU0432979614.USD","IDNA","SG9999001176.SGD","IE00BJT1NW94.SGD","VRTX","LU2468319806.SGD","BBH","VERX","BK4588","LU2362541273.HKD","BK4109","LU0079474960.USD","LU0234570918.USD","IE00B19Z9P08.USD","SGXZ57979304.SGD","BK4532","LU0757428866.USD","LU0417517546.SGD","BIB","IE0009355771.USD","PBE","TBXU","IBBQ","LU0061475181.USD","LU0058720904.USD","SG9999001176.USD","LU0566484027.USD","MTX","LU1674673428.USD","LU2462157665.USD","IE00BZ9MQY76.HKD","LU1430594728.SGD","LU1093756325.SGD","IE00B894F039.SGD","LU0256863811.USD","BK4533","IBB","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667668081","title":"Analysts Offer Insights on Healthcare Companies: Revolution Medicines (RVMD) and Cooper Co (COO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2667668081","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667668081?lang=en_us&edition=fundamental","pubTime":"2026-09-14 01:20","pubTimestamp":1789320035,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Revolution Medicines (RVMD) and Cooper Co (COO) with...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-revolution-medicines-rvmd-and-cooper-co-coo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-revolution-medicines-rvmd-and-cooper-co-coo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","LU0029874061.USD","BK4137","LU2272731782.SGD","BK4585","IDNA","RVMD","COO","GB00BDT5M118.USD","LU2211815571.USD","IE0009354923.USD","LU0320765992.SGD","BK4581","IE00B4R5TH58.HKD","LU0889565916.HKD","PTH","XBI","HCSG","LABU","IE0002141913.USD","XLV","IE0009355771.USD","IE00B2B36J28.USD","IE00BJT1NW94.SGD","BK4588","BBH","LU0109394709.USD","IE00BJJMRZ35.SGD","LU1992135399.USD","LU1992135472.HKD","BK4139","IE00BFTCPJ56.SGD","LU2272731600.USD","CANC","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666509524","title":"Heart Disease, a Historic Strength for Big Pharma, Becomes a Weakness - Heard on the Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2666509524","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666509524?lang=en_us&edition=fundamental","pubTime":"2026-09-12 17:30","pubTimestamp":1789205400,"startTime":"0","endTime":"0","summary":"There is a strange paradox haunting healthcare investing right now.Heart disease remains humanity's top killer, yet for drugmakers and Wall Street, it is becoming one of the hardest places to make mon","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0640476718.USD","LU0316494557.USD","IE00BJJMRY28.SGD","LU2023250504.SGD","LU2242652126.USD","LU2750360997.AUD","LU1712237335.SGD","VHT","LU2462157665.USD","LU1983299246.USD","IE00BN29S564.USD","LU0158827948.USD","LU0109391861.USD","LU0174119429.USD","LU0889565916.HKD","IE00B1XK9C88.USD","PJP","LU1366192091.USD","LU0345770308.USD","CANC","LU1127390331.HKD","LU1145028129.USD","LU2361044865.SGD","LU2896262040.SGD","LU2471134952.CNY","LU2491050071.SGD","SG9999001176.USD","LU0354030438.USD","LU0432979614.USD","LU1804176565.USD","NVOX","SGXZ31699556.SGD","LU0823434740.USD","LLY","LU0320765489.SGD","LU1551013425.SGD","LU2168564495.EUR","LU2063271972.USD","TBXU","LU2357305700.SGD","LU0683600562.USD","LU0786609619.USD","LU1069344957.HKD","LU1691799644.USD","LU1323610961.USD","IHE","NVO","LU2264538146.SGD","LU2361044949.HKD","LU0823416689.USD","NVOH","LU0256863902.USD","IE00BJT1NW94.SGD","IE00BKDWB100.SGD","IXJ","LU0353189680.USD","TRUH","IYH","THNR","LU2552382215.SGD","IE00B2B36J28.USD","LU1629891620.HKD","BK4533","LU0353189763.USD","LU0882574139.USD","LU2028103732.USD","LU2168564149.EUR","LU1023059063.AUD","LU0225283273.USD","LU0466842654.USD","IE00B4JS1V06.HKD","LU1868836591.USD","LU0208291251.USD","SGXZ51526630.SGD","LU1868836914.USD","BK4532","LU0471298777.SGD","LU2468319806.SGD","SG9999014880.SGD","SG9999018857.SGD","LU0058720904.USD","LU2237443622.USD","LU0943347566.SGD","MEDI","SGXZ99366536.SGD","LU0823434583.USD","IE00BWXC8680.SGD","IE00BFSS7M15.SGD","LU0234572021.USD","IE0001KFT4U8.USD","LU0106261372.USD","LU1720051108.HKD","LU2023251221.USD","LU2112291526.USD","LU0079474960.USD","LU0154236417.USD","IE00B775H168.HKD","SG9999017495.SGD","AMGN","LU1093756325.SGD","LU1280957306.USD","LU2324357040.USD","SG9999001440.SGD","LU2746668974.SGD","BK4534","LU2461242641.AUD","LU1064131342.USD","LU2237438978.USD","LU2236285917.USD","LU0094547139.USD","PPH","LU1868837300.USD","OZEM","BK4566","LU1232071149.USD","IE00BZ1G4Q59.USD","LU0868494617.USD","LU0456855351.SGD","SG9999013999.USD","LU0096364046.USD","LU0820561818.USD","SG9999014906.USD","BK4599","LU0109394709.USD","LU0417517546.SGD","LU2552382058.USD","LU0203202063.USD","LU0964807845.USD","LU1061106388.HKD","LU1551013342.USD","LU2746668461.USD","LU2089984988.USD","LU0471298694.HKD","SG9999001176.SGD","BIB","LU1035775433.USD","XLV","LU2237443465.HKD","LU2237443549.SGD","IBB","SG9999015986.USD","PBE","LU1571399168.USD","SG9999014898.SGD","AGNG","LU0238689110.USD","LU1623119135.USD","IE00BJJMRX11.SGD","IE0004445239.USD","LU0385154629.USD","NVS","BK4581","HRTS","IE00BFTCPJ56.SGD","LU2168564065.EUR","LU2360106947.USD","LU2265009873.SGD","LU2271345857.HKD","LU2602419157.SGD","GB00BDT5M118.USD","LU2552382132.HKD","SGXZ57979304.SGD","SGXZ81514606.USD","LU2237443382.USD","LU0256863811.USD","LU2237443895.HKD","LU2491050154.USD","BK4516","LU2456880835.USD","LU1057294990.SGD","LU2242646821.SGD","LU0689472784.USD","IE00BK4W5L77.USD","GDOC","LU1868837136.USD","MEDX","LU1267930730.SGD","LLYX","LU1979441026.SGD","IE0002141913.USD","LU2023250330.USD","LU0006306889.USD","LU2108987350.USD","IE00BJJMRZ35.SGD","LU2213496289.HKD","BK4578","LU2491049909.HKD","JDOC","LU0354030511.USD","LU0672654240.SGD","LU2471134796.USD","RXL","LU1988902786.USD","SG9999015945.SGD","LU1720051017.SGD","BK4585","LU0820562030.AUD","LU0266013472.USD","LU2168563687.JPY","LU2361045086.USD","SG9999015978.USD","LU1989771016.USD","LU0097036916.USD","FTXH","LU0122379950.USD","LU0320765992.SGD","IBBQ","LU2471134879.HKD","TMED","LU0708995401.HKD","LLII","LU2087625088.SGD","LU0133085943.USD","IE0009355771.USD","LU0211331839.USD","LU1868836757.USD","SG9999018865.SGD","LU2089283258.USD","LU2417539215.USD","BK4139","LU0320765059.SGD","WDNA","LU2756315664.SGD","MHIP","LU2462591350.SGD","LU0203201768.USD","FHLC","LU0882574055.USD","BBH","LU0289739699.SGD","LU1291159041.SGD","LU1917777945.USD","IE00BFSS8Q28.SGD","LU1814569148.SGD","IE0005OL40V9.USD","LU2089284900.SGD","LU2237443978.SGD","IE00B7KXQ091.USD","IE00BKPKM429.USD","LU0061475181.USD","LLYZ","LU0323591593.USD","IE00BKVL7J92.USD","LU1548497426.USD","ILDR","LU0198837287.USD","LU0820561909.HKD","LU2756315318.SGD","IE00B1BXHZ80.USD","LU2211815571.USD","SG9999014914.USD","ELIL","LU0787776722.HKD","BK4588","04332","SG9999015952.SGD","LU0345770993.USD","CURE","IE0004445015.USD","LU2168564222.USD","LU2471134523.USD","IE00BK4W5M84.HKD","LU0070302665.USD","LU1093756168.USD","LU2106854487.HKD","NVOC","LU0114720955.EUR","IE00B4R5TH58.HKD","LU0158827781.USD","LU2111349929.HKD","BK4007","LU0210536198.USD","LU2750360641.GBP","ELIS","IE00BJLML261.HKD","LU1974910355.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":10,"totalSize":200,"code":"91000000","status":"200"}]}}